HUP0300860A3 - Pharmaceutical compositions suitable for treatment of urinary dysfunction - Google Patents

Pharmaceutical compositions suitable for treatment of urinary dysfunction

Info

Publication number
HUP0300860A3
HUP0300860A3 HU0300860A HUP0300860A HUP0300860A3 HU P0300860 A3 HUP0300860 A3 HU P0300860A3 HU 0300860 A HU0300860 A HU 0300860A HU P0300860 A HUP0300860 A HU P0300860A HU P0300860 A3 HUP0300860 A3 HU P0300860A3
Authority
HU
Hungary
Prior art keywords
treatment
pharmaceutical compositions
compositions suitable
urinary dysfunction
urinary
Prior art date
Application number
HU0300860A
Other languages
English (en)
Original Assignee
Intreat Pty Ltd Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Ltd Sydney filed Critical Intreat Pty Ltd Sydney
Publication of HUP0300860A2 publication Critical patent/HUP0300860A2/hu
Publication of HUP0300860A3 publication Critical patent/HUP0300860A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
HU0300860A 2000-08-28 2001-08-28 Pharmaceutical compositions suitable for treatment of urinary dysfunction HUP0300860A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9687A AUPQ968700A0 (en) 2000-08-28 2000-08-28 Treatment of urinary incontinence
PCT/AU2001/001079 WO2002017929A1 (en) 2000-08-28 2001-08-28 Treatment of urinary dysfunction

Publications (2)

Publication Number Publication Date
HUP0300860A2 HUP0300860A2 (hu) 2003-11-28
HUP0300860A3 true HUP0300860A3 (en) 2005-03-29

Family

ID=3823741

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300860A HUP0300860A3 (en) 2000-08-28 2001-08-28 Pharmaceutical compositions suitable for treatment of urinary dysfunction

Country Status (19)

Country Link
US (1) US20040067967A1 (hu)
EP (1) EP1315503A4 (hu)
JP (1) JP2004506744A (hu)
KR (1) KR20030034162A (hu)
CN (2) CN101164541A (hu)
AU (1) AUPQ968700A0 (hu)
BR (1) BR0113667A (hu)
CA (1) CA2420846A1 (hu)
CZ (1) CZ2003807A3 (hu)
EA (1) EA007092B1 (hu)
EE (1) EE200300082A (hu)
HU (1) HUP0300860A3 (hu)
IL (1) IL154642A0 (hu)
MX (1) MXPA03001833A (hu)
NO (1) NO20030978L (hu)
NZ (1) NZ537643A (hu)
PL (1) PL360368A1 (hu)
WO (1) WO2002017929A1 (hu)
ZA (1) ZA200302340B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148394A1 (en) * 2002-01-18 2003-08-07 Millennium Pharmaceuticals, Inc. Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058, or 6351 molecules
US20050143323A1 (en) * 2003-12-30 2005-06-30 Henley E. C. Isoflavone therapy for treating urinary incontinence
KR100462173B1 (ko) * 2004-06-08 2004-12-16 안국약품 주식회사 요실금 예방 및 치료용 조성물
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
JP4987871B2 (ja) * 2005-08-15 2012-07-25 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３アンタゴニストとしてのピペリジン及びピペラジン誘導体
WO2007143607A2 (en) 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
BRPI0719955B1 (pt) * 2006-10-04 2024-01-09 F. Hoffmann-La Roche Ag Processo para síntese de derivados de fenóxi diaminopirimidina
US8277426B2 (en) 2009-09-30 2012-10-02 Wilcox Heather J Male urinary incontinence device
JP7127021B2 (ja) 2016-10-21 2022-08-29 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 細胞傷害性粒子
JP6813717B1 (ja) * 2019-10-02 2021-01-13 あすか製薬株式会社 排尿障害改善剤
WO2021065027A1 (ja) * 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985603A (en) * 1994-05-27 1999-11-16 Glaxo Group Limited P2x receptor DNA and protein sequence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5856129A (en) * 1996-10-30 1999-01-05 Incyte Pharmaceuticals, Inc. DNA encoding a human purinoceptor

Also Published As

Publication number Publication date
EA200300264A1 (ru) 2003-10-30
EA007092B1 (ru) 2006-06-30
NO20030978D0 (no) 2003-02-28
EP1315503A4 (en) 2005-02-09
ZA200302340B (en) 2004-06-28
KR20030034162A (ko) 2003-05-01
EP1315503A1 (en) 2003-06-04
PL360368A1 (en) 2004-09-06
NZ537643A (en) 2006-04-28
MXPA03001833A (es) 2004-11-01
EE200300082A (et) 2004-12-15
BR0113667A (pt) 2003-06-03
CN101164541A (zh) 2008-04-23
HUP0300860A2 (hu) 2003-11-28
WO2002017929A1 (en) 2002-03-07
CA2420846A1 (en) 2002-03-07
US20040067967A1 (en) 2004-04-08
NO20030978L (no) 2003-04-16
IL154642A0 (en) 2003-09-17
CZ2003807A3 (cs) 2003-08-13
CN1479621A (zh) 2004-03-03
AUPQ968700A0 (en) 2000-09-21
JP2004506744A (ja) 2004-03-04

Similar Documents

Publication Publication Date Title
HUP0101543A3 (en) Pharmaceutical compositions for treating femal sexual dysfunction
AU7174101A (en) Pharmaceutical compositions of estrogenic agents
HUP0301892A3 (en) Pharmaceutical compositions for treatment of sexual dysfunction and their preparation
HUP0101268A3 (en) Pharmaceutical compositions for treating female sexual dysfunction
HUP0303271A3 (en) Use of rapamycin for preparation of pharmaceutical composition suitable for cancer treatment
HUP0100586A3 (en) Pharmaceutical compositions treating lower urinary tract symptoms
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
AU5160201A (en) Compositions comprising natural agents for treatment of cancer
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
HUP0300860A3 (en) Pharmaceutical compositions suitable for treatment of urinary dysfunction
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
GB0130219D0 (en) Compounds for the treatment of sexual dysfunction
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
PL362980A1 (en) Treatment of sexual dysfunction
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
HUP0303046A3 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence and pharmaceutical compositions containing them
PL1687006T3 (pl) Kompozycje farmaceutyczne do leczenia zaburzeń czynności nerek
HUP0002508A3 (en) Pharmaceutical compositions for treatment of migraine
HK1046848A1 (en) Specific therapeutic composition for treating aids
EP1333862A4 (en) PHARMACEUTICAL METHODS AND COMPOSITIONS FOR IMPROVING THE ESTABLISHMENT OF EMBRYOS
AU2003283153A8 (en) Pharmaceutical compositions for the treatment of urinary incontinence
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis
AU2001281396A1 (en) Novel compositions and methods for treatment of male erectile dysfunction
AU8160701A (en) Treatment of urinary dysfunction